Skip to main content
MedVellum
MCQsExamsAtlas
DashboardPricing
MBBS / Core medicine✳Dermatology✳ICU Fellowship (CICM)✳Anaesthesia✳Emergency Medicine✳Psychiatry Fellowship✳Paediatrics Fellowship✳Physician Medicine✳MCQs✳SAQs✳Vivas✳OSCE✳Evidence-first✳MBBS / Core medicine✳Dermatology✳ICU Fellowship (CICM)✳Anaesthesia✳Emergency Medicine✳Psychiatry Fellowship✳Paediatrics Fellowship✳Physician Medicine✳MCQs✳SAQs✳Vivas✳OSCE✳Evidence-first✳

MedVellum.

The folio

Exam-exhaustive medical education across every specialty — evidence-graded topics, engraved plates, and practice in every written and oral format. Educational content only — not medical advice.

llms.txt · psychiatry LLM catalog · sitemap

Atlas

  • Specialty atlas
  • MBBS / Core medicine
  • Dermatology
  • ICU Fellowship (CICM)
  • Anaesthesia
  • Emergency Medicine
  • Psychiatry Fellowship
  • Paediatrics Fellowship
  • Physician Medicine

Study & account

  • MCQ practice
  • Practice alias
  • Exam tools
  • Dashboard
  • Pricing
  • Sign in

© 2026 MedVellum. For education only — not a substitute for clinical judgement.

Folio edition · Set in Instrument Serif & Archivo

Paeds SAQsendocrinology-diabetes-and-growth

Paeds SAQs · endocrinology-diabetes-and-growth

Tall stature and overgrowth syndromes — formative SAQs

Formative SAQs on tall stature and overgrowth syndromes: separating the familial normal variant from the pathological causes using a structured redistribution assessment, recognising the syndromic overgrowth fingerprint (Sotos, Beckwith-Wiedemann, Weaver), the tumour surveillance that the molecular subgroup dictates, and the treatable endocrine and chromosomal causes.

20 marks30 min
On this page & tools

Target exams

RACP General PaediatricsMRCPCH ClinicalRACP DWE

Target exams

RACP General PaediatricsMRCPCH ClinicalRACP DWE
Prompt
Tall stature and overgrowth syndromes in paediatric practice

SAQ 1 (10)

A large-for-gestational-age term infant is reviewed at six weeks of age. The mother notes the baby's tongue seems large and protrudes, and the umbilicus has not healed well. On examination the baby is on the 99.6th centile for weight and length, has a markedly enlarged tongue, a soft umbilical hernia, and the left leg is measurably longer and thicker than the right. [2] [9]

a) What is the most likely diagnosis, and which molecular test confirms it and defines the tumour-risk subgroup? Give the reasoning. (3 marks) [2]

b) Outline the tumour surveillance plan this child must now enter, including the imaging modality, the frequency, the age horizon, and the tumours targeted. (3 marks) [9]

c) Describe the neonatal complications that may have required management in the first days of life, naming at least three. (2 marks) [2]

d) The parents ask whether their next child will be affected. Outline the principles of the recurrence-risk counselling for this condition. (2 marks) [2]

SAQ 2 (10)

A seven-year-old boy is referred because he is the tallest in his class. His father is 193 cm and his mother 180 cm. He is well, his development is normal, and his height is on the 99.6th centile with a growth velocity tracking along the centile. His bone age is two years advanced. His teacher reports he is bright but socially awkward, and on examination he has a prominent forehead, a receding hairline, a long narrow face, and large hands and feet. [1] [6]

a) What is the most likely diagnosis, and which gene is responsible? Explain why the advanced bone age and the facial features redirect the child away from the familial-tall-stature label. (3 marks) [1] [8]

b) Outline the further assessment and investigation that this child needs, including the developmental and the genetic work-up. (3 marks) [6] [1]

c) Contrast this child's prognosis and management with that of a child with familial tall stature. (2 marks) [6]

d) A different tall child, aged seven, has precocious puberty. Explain the paradox by which this child is tall now but will be short at final height, and name the intervention that changes the trajectory. (2 marks) [6]

References

  1. [1]Adam MP, Bick S, Mirzaa GM, et al. Sotos Syndrome. GeneReviews, 1993.PMID 20301652
  2. [2]Brioude F, Kalish JM, Mussa A, et al. Expert consensus document: Clinical and molecular diagnosis, screening and management of Beckwith-Wiedemann syndrome. Nat Rev Endocrinol, 2018.PMID 29377879
  3. [6]Caro R, Savel P, Moss PI. Evaluation of Short and Tall Stature in Children. Am Fam Physician, 2025.PMID 40531152
  4. [8]Tatton-Brown K, Loveday C, Yost S, et al. Mutations in Epigenetic Regulation Genes Are a Major Cause of Overgrowth with Intellectual Disability. Am J Hum Genet, 2017.PMID 28475857
  5. [9]Maas SM, Vansenne F, Kadouch DJ, et al. Phenotype, cancer risk, and surveillance in Beckwith-Wiedemann syndrome depending on molecular genetic subgroups. Am J Med Genet A, 2016.PMID 27419809